Loading clinical trials...
Loading clinical trials...
A Randomized, Open Label, Single Dose Pharmacokinetic and Safety Study of Implantable Long Acting 3-month Naltrexone Subcutaneous Pellets Compared to Naltrexone IM Injection (Vivitrol) in Healthy Volunteers
Conditions
Interventions
BICX104
Vivitrol
Locations
1
United States
Orange County Research Center
Tustin, California, United States
Start Date
June 17, 2022
Primary Completion Date
February 22, 2023
Completion Date
March 22, 2023
Last Updated
August 16, 2023
NCT04197921
NCT04379115
NCT04354077
NCT04173416
NCT03135886
NCT04458545
Lead Sponsor
BioCorRx Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions